Barry E. Greene

2015 - Alnylam Pharmaceuticals

In 2015, Barry E. Greene earned a total compensation of $5.3M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 559% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$261,247
Option Awards$4,465,293
Salary$530,450
Other$7,896
Total$5,264,886

Greene received $4.5M in option awards, accounting for 85% of the total pay in 2015.

Greene also received $261.2K in non-equity incentive plan, $530.5K in salary and $7.9K in other compensation.

Rankings

In 2015, Barry E. Greene's compensation ranked 1,491st out of 13,638 executives tracked by ExecPay. In other words, Greene earned more than 89.1% of executives.

ClassificationRankingPercentile
All
1,491
out of 13,638
89th
Division
Manufacturing
530
out of 5,187
90th
Major group
Chemicals And Allied Products
196
out of 1,857
89th
Industry group
Drugs
150
out of 1,531
90th
Industry
Pharmaceutical Preparations
121
out of 1,179
90th
Source: SEC filing on March 17, 2016.

Greene's colleagues

We found four more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2015.

2015

David-Alexandre Gros

Alnylam Pharmaceuticals

Senior Vice President, Chief Business Officer

2015

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2015

Akshay Vaishnaw

Alnylam Pharmaceuticals

Chief Medical Officer

2015

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer principal financial officer

News

In-depth

You may also like